Overview
Legal name
LBN INNOVATIONS LTD
Region
Unknown
Registered address
1 CROWN CLOSE
LONDON
ENGLAND
E3 2JH
Insolvency history
No
Company
Active
LTD
Company profile
LBN Innovations Ltd
LBN Innovations Ltd is a UK company with status active founded in 2021.
CRN
13140072
Founded
2021
Age
5
Latest accounts
Financial period: 1 Feb 2024 to 31 Jan 2025
FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
1
Company events
Reference milestones and recent Companies House filing stream events.
6 events
31 Jan
2027
Confirmation statement due
Confirmation DueNext confirmation statement due date
31 Oct
2026
Accounts due
Accounts DueNext accounts due date
17 Jan
2026
Confirmation statement filed
ConfirmationLast confirmation statement made up date
31 Jan
2025
Accounts filed
AccountsLast accounts made up date
27 Sep
2024
Accounts With Accounts Type Micro Entity
Accounts AnalysedAA | Transaction MzQzNzU0NjMzNWFkaXF6a2N4
Published 27 Sep 2024 02:59
18 Jan
2021
Incorporated
InceptionCompany registered at Companies House
Public funding
2 awards
First funded
2022
Funded years
2022, 2023, 2024
Age at first award
1 years
Projects
2024
Collaborative R&D
Lead participant
LBN Digital Speculum Replacement
1 May 2024 to 30 Apr 2025
Awarded
£100,000
Total cost £100,000
LBN Innovations is actively involved in the development of a digital medical device designed for both clinical and eventual home use, with the explicit goal of revolutionising the existing cervical screening apparatus. This innovative device, meticulously crafted to suit the female anatomy, aims to address challenges related to screening participation, sp...
2023
Grant for R&D
Lead participant
Home Cervical Smear Test
1 Apr 2023 to 31 Mar 2024
Awarded
£50,000
Total cost £50,000
99.7% of cervical cancer is caused by HPV. Pre-malignant changes to the uterine cervix can take approximately 10 years to develop following HPV infection. This means that if the pre-cancerous mutations are caught early, then cervical cancer may be prevented. In 1988, the NHS Cervical Screening Programme was established and is estimated to have saved up to...
2022
Grant for R&D
Lead participant
Home Cervical Smear Test
1 Nov 2022 to 30 Apr 2023
Awarded
£48,235
Total cost £48,235
99.7% of cervical cancer is caused by Human Papillomavirus (HPV). Pre-malignant changes to the uterine cervix can take approximately 10 years following HPV infection to develop. This means that if the pre-cancerous mutations are caught early, then cervical cancer may be prevented. In 1988, the NHS Cervical Screening Programme was established and is estima...
Product types
Collaborative R&D
Grant for R&D